F 0686
Provide appropriate pressure ulcer care and prevent new ulcers from developing.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to follow a physician's treatment order for a
resident (R1) with a stage 3 pressure injury to the sacrum. The facility also failed to inform R1's physician of
a newly identified pressure injury wound. This applies to 1 of 4 residents reviewed for pressure injuries.
Residents Affected - Few
The findings include:
R1's EMR (Electronic Medical Record) showed R1 had an unhealed chronic stage 3 pressure injury to his
sacrum. R1's Braden Scale assessment dated [DATE] showed R1 was at a High Risk for pressure injuries.
R1's care plan dated 12/10/2024 showed R1's wound interventions included Treatment as ordered and
Wound care consultation as ordered.
On 12/10/2024 at 11 AM, R1 was in bed. R1 said last night he had discomfort in his wound area. R1 said
he felt as if something was pinching him.
On 12/10/2024 at 10:30 AM, V3 (Wound Care Nurse/WCN) was asked to perform wound care to R1's
sacral wound. V6 (Hospice Aide) assisted V3 (WCN) with turning R1 in bed for wound care. R1 had an
unsecured ABD pad dressing loosely covering his sacrum and buttocks. V3 removed the ABD dressing,
and there was a dry 4x4 gauze dressing covering the sacral wound bed. The gauze dressing was adherent
to the wound bed and stained with dry serosanguinous drainage, V3 had to moisten the gauze with normal
saline to remove the dressing. The peri-wound area was red and irritated, and R1's right buttock had a
partially open maroon blister that was bleeding. V3 said it appeared like a popped blood blister. V3 said it
was a new DTI (deep tissue injury) pressure wound that measured 4 x 1.5 x 0.5 cm (centimeters). V3
proceeded to clean both wounds and then applied Nystatin (antifungal) cream directly on the sacral wound
bed then covered it with a Calcium Alginate dressing. V3 then covered both wounds with an adherent
boarded foam dressing.
On 12/10/2024 at 1:30 PM, V3 (WCN) said she changed R1's daily sacral wound dressings. V3 said R1's
wound was chronic, and would close and reopen. V3 said she had noticed R1's wound bleeding at times
and was unsure of the cause. V3 said she does not follow R1's ordered treatment because she feels that
the ABD dressing would provide more cushion versus the ordered foam dressing. V3 also said she did not
follow the treatment order for the foam dressing because she felt it would not stay on properly. V3 continued
to say that she had notified V12 (Wound Physician) of R1's new right buttock wound in the morning and
entered a wound care order in R1's EMR.
On 12/10/2024 at 3 PM, V12 (Wound Physician) said he had been treating R1's sacral wound for a long
time. V12 said the wound would heal and then reopen. V12 said R1 was at high risk for skin
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
146008
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
146008
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/11/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Alden of Waterford
2021 Randi Drive
Aurora, IL 60505
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0686
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
breakdown because of his complex medical conditions and poor oral intake. V12 said that based on R1's
medical conditions and end-life care his wounds were determined to be unavoidable. However, he still
expected to be notified of any skin alterations immediately to ensure proper wound care would be initiated.
V12 confirmed that V3 had not notified him of R1's new right buttock wound once it was identified in the
morning. V12 continued to say that he expected his wound care orders to be followed as prescribed. V12
said an ABD dressing was not the same as a foam dressing because a foam dressing provided better
protection for R1's wound. V12 also said R1's dressings had to be properly secured to ensure proper
covering of the open wound bed to prevent possible complications.
R1's WASA Form dated 12/10/2024 (completed during the survey) showed R1 had a new DTI pressure
wound to his right buttock. The form said the wound measured 4 x 1.5 x 0 cm with bloody exudate drainage.
The form said Noted with Skin Injury to Right buttocks. 25% of the area is open, 75% skin is intact but is
dark red/purple.
R1's Order Summary Report showed an active treatment order for R1's sacral wound initiated on 11/1/2024
for Maxorb II 4 x 4 Apply to sacral topically every day shift for Skin Condition Clean area with NS, apply
calcium ag, cover with dressing, apply mycolog in periwound area. The order did not include V12's order for
a foam cover dressing.
R1's Order Summary Report also showed another treatment order for his right buttock initiated on
12/10/2024 for Maxorb II Ag 4 x 4.75 Apply to Right buttock topically every day shift for Skin Condition
CLEANSE AREA W/NS, APPLY MAXORB, AND COVER WITH FOAM DRESSING.
R1's Wound Physician Consultation report dated 12/11/2024 showed R1's sacral wound measured 5.5 x
2.8 x 0.2 cm with moderate serosanguinous exudate and the peri-wound was denuded. The report also
showed a current treatment order initiated on 10/30/2024 to cleanse the wound with normal saline then
apply topically a calcium alginate dressing and apply Mycolog to the peri-wound area and cover with a
foam dressing daily.
The report continued to show R1's new right buttock wound was also assessed. The report said the
pressure injury was a stage 3, measuring 3.6 x 2 x 0.2 cm with moderate serosanguinous drainage. The
report showed V12's (Wound Physician) treatment order was to cleanse the wound with normal saline then
apply a calcium alginate dressing and apply Mycolog to the peri-wound area and cover with a foam
dressing daily.
The facility's document titled Job Description Titled: Wound Care Coordinator dated 11/2021, said Essential
Functions A. Must ensure that all nursing procedures and protocols are followed in accordance with
established policies .E. Administer or assist with wound treatments as ordered by the physician. F. Review
treatment orders for completeness of information and accuracy of transcription of the physician's order .M.
Update the family/responsible party and attending physician for any changes on wound assessments .P.
Consult with other nurses, management, and other related health professionals to assist in assessing,
planning and delivering and evaluating patient care .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
146008
If continuation sheet
Page 2 of 2